FDA Clears Medtronic’s LigaSure RAS Maryland Jaw Device For Use With Hugo Robotic-Assisted Surgery System

Medtronic (NYSE: MDT) has received FDA clearance for its LigaSure RAS Maryland jaw device, which is now approved for use with the Hugo robotic-assisted surgery system. This device, which has been utilized in over 45 million procedures globally, enhances the instrument offerings for robotic-assisted surgeries in the U.S. The approval aligns with the increasing demand for trusted energy instruments in robotic workflows as the adoption of robotic-assisted surgery continues to grow.